SCHEMBL5848629

SCHEMBL5848629

CCc1nn2ccccc2c1N(CCCF)CCOC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 9/20 0.40
EGFR P00533 1/20 0.32
KCNH2 Q12809 1/20 0.31
HDAC1 Q13547 1/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31
HTR1A P08908 1/20 0.31
DRD2 P14416 1/20 0.31
DRD4 P21917 1/20 0.31
DRD3 P35462 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
CASP1 P29466 1/20 0.30
KLK7 P49862 1/20 0.30
CASP7 P55210 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5848557 0.93 CRHR1 (0.38) CRHR1EGFRKCNH2HDAC1PIK3CD
SCHEMBL5847203 0.87 CRHR1 (0.39) CRHR1EGFRKCNH2HDAC1HTR1A
SCHEMBL5849728 0.82 APP (0.38) CRHR1EGFRKCNH2HDAC1HTR1A
SCHEMBL5847587 0.80 CRHR1 (0.49) CRHR1
SCHEMBL5848036 0.79 DRD2 (0.34) CRHR1KCNH2HDAC1HTR1ADRD2
SCHEMBL5848888 0.79 CRHR1 (0.45) CRHR1EGFRKCNH2HDAC1HTR1A
SCHEMBL5847343 0.78 HDAC1 (0.35) CRHR1EGFRKCNH2HDAC1KDM4E
SCHEMBL5848728 0.76 HDAC1 (0.37) CRHR1EGFRKCNH2HDAC1HTR1A
SCHEMBL5848399 0.76 MYC (0.37) CRHR1EGFRKCNH2HDAC1HTR1A
SCHEMBL5849798 0.73 HDAC1 (0.35) EGFRKCNH2HDAC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7151109-B2 Pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators PHARMACIA & UPJOHN COMPANY LLC (US) 2006-12-19 US disclosed
US-20040002511-A1 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators PHARMACIA & UPJOHN COMPANY 2004-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002511-A1 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators CRHR1, HTR5A, CRH CRHR1 1/4885EGFR 1409/4885KCNH2 2731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.